Latest tumor Stories
50% of Patients Treated with Mipsagargin had No Tumor Growth at Four Months SAN ANTONIO, Sept. 8, 2014 /PRNewswire/ -- GenSpera, Inc.
Global research initiative to investigate long-term glioblastoma survivors. Chicago, IL (PRWEB) September 03, 2014 The American Brain Tumor Association
Doctors at Atlantic NeuroSurgical Specialists (ANS) have added a new and innovative form of therapy to their treatment arsenal in the battle against glioblastoma multiforme (GBM).
The Jeffrey Epstein VI Foundation funds a study showing tumor growth. NEW YORK, Aug.
VAL-083 Phase I/II VAL-083 clinical trial advances to 50mg/m(2) cohort VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.
A smart technology which involves smuggling gold nanoparticle into brain cancer cells has proven highly effective in lab-based tests
IRVING, Texas, Aug.
Patented Technology Enables Accurate Delivery of a Chemotherapeutic Drug to Targeted Tumor Cells, Reducing Drug-related Toxicity without Sacrificing Therapeutic Impact SYDNEY, Aug.
A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma.
- a meat pie that is usually eaten at Christmas in Quebec